|
| |
| | | 50265 | | 27.08.1991 | | Roche Pharma (Schweiz) AG | | | | | | | | | | | | | | | 01.01.2004 | | | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Recormon 1000 U.I./1 mL | Injektionspräparat | Injection preparation (Epoetin Beta 1000 UI) | B03XA01 | | | 02 | Recormon 5000 U.I./1 mL | Injektionspräparat | Injection preparation (Epoetin Beta 5000 UI) | B03XA01 | | | 03 | Recormon 10'000 U.I./mL | Injektionspräparat | Injection preparation (Epoetin Beta 10000 UI) | B03XA01 | | | 07 | Recormon 2000 U.I./1 mL | Injektionspräparat | Injection preparation (Epoetin Beta 2000 UI) | B03XA01 | | | 09 | Recormon 500 U.I./0 | Injektionspräparat | Injection preparation (Epoetin Beta 500 UI) | B03XA01 | |
|
|
|
